These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 10946807

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Clinical significance of IgM deposition in the mesangium and mesangial hypercellularity in adult minimal change nephrotic syndrome].
    Maruyama M, Toyoda M, Umezono T, Miyauchi M, Yamamoto N, Kimura M, Honma M, Nishina M, Endoh M, Sakai H, Suzuki D.
    Nihon Jinzo Gakkai Shi; 2006; 48(1):14-21. PubMed ID: 16480062
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. HLA class I typing in Egyptian childhood minimal change nephrotic syndrome.
    Donia AF, Ismail AM, Moustafa Fel-H.
    J Nephrol; 2008; 21(5):734-7. PubMed ID: 18949728
    [Abstract] [Full Text] [Related]

  • 9. [Clinico-pathological evaluation of mesangial IgA deposition of minimal change with nephrotic syndrome].
    Hamaguchi K, Tuchida H, Suzuki S, Miura Y, Nakazawa R, Suhara Y, Mimura N.
    Nihon Jinzo Gakkai Shi; 1990 Oct; 32(10):1071-7. PubMed ID: 2287099
    [Abstract] [Full Text] [Related]

  • 10. [Incidental mesangial IgA deposition in minimal change nephrotic syndrome(MCNS)].
    Tsukada M, Honda K, Nitta K, Yumura W, Nihei H.
    Nihon Jinzo Gakkai Shi; 2003 Oct; 45(7):681-8. PubMed ID: 14631763
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The primary nephrotic syndrome in children and histopathologic study.
    Kirdpon S, Vuttivirojana A, Kovitangkoon K, Poolsawat SS.
    J Med Assoc Thai; 1989 Jan; 72 Suppl 1():26-31. PubMed ID: 2732642
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Clinicopathologic correlation of C1q nephropathy in children.
    Fukuma Y, Hisano S, Segawa Y, Niimi K, Tsuru N, Kaku Y, Hatae K, Kiyoshi Y, Mitsudome A, Iwasaki H.
    Am J Kidney Dis; 2006 Mar; 47(3):412-8. PubMed ID: 16490619
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Up-regulation of TRAIL mRNA expression in peripheral blood mononuclear cells from patients with minimal-change nephrotic syndrome.
    Okuyama S, Komatsuda A, Wakui H, Aiba N, Fujishima N, Iwamoto K, Ohtani H, Sawada K.
    Nephrol Dial Transplant; 2005 Mar; 20(3):539-44. PubMed ID: 15671071
    [Abstract] [Full Text] [Related]

  • 18. Enhanced suppressor T cell activity resulting in increased IgM and decreased IgG productions in children with minimal change nephrotic syndrome.
    Chen CH, Hsieh KH, Lee PP.
    Int J Pediatr Nephrol; 1987 Mar; 8(2):75-80. PubMed ID: 2958423
    [Abstract] [Full Text] [Related]

  • 19. Comparison of lipid and fatty acid metabolism between minimal change nephrotic syndrome and membranous nephropathy.
    Fujita T, Nakamura N, Kumasaka R, Shimada M, Murakami R, Osawa H, Yamabe H, Okumura K.
    In Vivo; 2006 Mar; 20(6B):891-3. PubMed ID: 17203785
    [Abstract] [Full Text] [Related]

  • 20. [Histologic transition in patients with minimal-change nephrotic syndrome to mesangial IgM nephropathy].
    Claros González I, Baños Gallardo M, Forascepi Roza R, Argüelles Toraño M.
    Rev Clin Esp; 1986 Dec; 179(9):476-7. PubMed ID: 3809684
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.